Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

NCT01762150 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Sorafenib
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]